Intranasal Vaccination Using Interleukin-12 and Cholera Toxin Subunit B as Adjuvants To Enhance Mucosal and Systemic Immunity to Human Immunodeficiency Virus Type 1 Glycoproteins
We have investigated the induction of protective mucosal immunity to human immunodeficiency virus type 1 (HIV-1) isolate 89.6 by intranasal (i.n.) immunization of mice with gp120 and gp140 together with interleukin-12 (IL-12) and cholera toxin subunit B (CTB) as adjuvants. It was found that both IL-...
Na minha lista:
| Udgivet i: | J Virol |
|---|---|
| Principais autores: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
2003
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154022/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12719551/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.10.5589-5597.2003 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
